Joseph Jorizzo to Drug Administration Schedule
This is a "connection" page, showing publications Joseph Jorizzo has written about Drug Administration Schedule.
Connection Strength
0.517
-
Yan BY, Jorizzo JL. Management of Morgellons Disease With Low-Dose Trifluoperazine. JAMA Dermatol. 2018 02 01; 154(2):216-218.
Score: 0.144
-
Menter A, Vamvakias G, Jorizzo J. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses. Cutis. 2008 Jun; 81(6):509-16.
Score: 0.074
-
Iorizzo LJ, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008 Jul; 59(1):99-112.
Score: 0.073
-
Neville JA, Williford PM, Jorizzo JL. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. J Drugs Dermatol. 2007 Sep; 6(9):910-4.
Score: 0.070
-
Jorizzo J, Dinehart S, Matheson R, Moore JK, Ling M, Fox TL, McRae S, Fielder S, Lee JH. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007 Aug; 57(2):265-8.
Score: 0.069
-
Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule. Cutis. 2004 Dec; 74(6 Suppl):18-23.
Score: 0.058
-
Moustafa FA, Sandoval LF, Jorizzo JL, Huang WW. Systemic treatment of papular dermatitis: A retrospective study. J Dermatolog Treat. 2015 Oct; 26(5):431-4.
Score: 0.029